Table 1.
Summary of quality control of RNA-seq results generated in the study.
| Group | Sample name | Raw reads (bp) | Clean reads (bp) | Q20 (%) | Q30 (%) | GC (%) | Mapped read | Mapping ratio (%) |
|---|---|---|---|---|---|---|---|---|
| Control | C-90028-1 | 45,097,848 | 44,323,338 | 98.99 | 97.09 | 37.36 | 41,827,145 | 94.37 |
| C-90028-2 | 41,389,912 | 40,709,300 | 98.95 | 96.99 | 37.36 | 38,409,668 | 94.35 | |
| C-90028-3 | 50,467,472 | 48,313,668 | 97.99 | 94.00 | 37.11 | 45,271,080 | 93.70 | |
| C-X27-1 | 40,857,914 | 40,122,876 | 98.97 | 97.04 | 37.11 | 37,042,163 | 92.32 | |
| C-X27-2 | 46,636,704 | 45,784,742 | 98.97 | 97.08 | 37.10 | 42,342,463 | 92.48 | |
| C-X27-3 | 48,267,404 | 46,184,228 | 98.11 | 94.40 | 37.48 | 41,671,692 | 90.23 | |
| EPA | E−90028-1 | 46,980,998 | 45,757,454 | 98.71 | 96.48 | 37.41 | 43,440,221 | 94.94 |
| E−90028-2 | 47,358,956 | 46,592,240 | 98.77 | 96.60 | 37.52 | 44,125,478 | 94.71 | |
| E−90028-3 | 46,548,132 | 45,796,242 | 98.74 | 96.54 | 36.96 | 43,203,889 | 94.34 | |
| E-X27-1 | 44,805,798 | 44,212,514 | 98.77 | 96.58 | 37.58 | 41,204,463 | 93.20 | |
| E-X27-2 | 43,859,334 | 43,322,624 | 98.75 | 96.52 | 37.45 | 40,301,513 | 93.03 | |
| E-X27-3 | 42,673,636 | 42,126,644 | 98.75 | 96.53 | 37.24 | 38,907,463 | 92.36 |